Chemical and Pharmaceutical Bulletin p. 541 - 550 (1994)
Update date:2022-09-26
Topics:
Fukushi
Mabuchi
Itoh
Terashita
Nishikawa
Sugihara
During the screening of novel platelet-activating factor (PAF) antagonists, we found that 1-(6-methoxy-3,4-dihydro-2-naphthoyl)-4-(3,4,5- trimethoxybenzyl)piperazine and its 4-(3,4,5-trimethoxybenzoyl)piperazine derivatives (1b, 2b) exerted in vitro and i
View Morewebsite:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai，HongKong
Nanjing Capatue Chemical Co., Ltd
Contact:+86-25-86371192 +86-025-85720158
Address:No.20 Jiangjun Avenue, Jiangning Economic & Technical Development Zone
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
website:http://www.tcfinechem.com/
Contact:18681346930
Address:baifu town,whou district
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Doi:10.1055/s-0035-1560090
(2015)Doi:10.1021/ja309677h
(2013)Doi:10.1055/s-1974-23272
(1974)Doi:10.1016/S0957-4166(02)00785-1
(2003)Doi:10.1021/ja01169a524
(1949)Doi:10.1016/0022-328X(96)06159-1
(1996)
